2,842
Views
33
CrossRef citations to date
0
Altmetric
Reviews

Acute lamotrigine overdose: a systematic review of published adult and pediatric cases

, , &
Pages 81-89 | Received 29 Mar 2017, Accepted 17 Aug 2017, Published online: 01 Sep 2017

References

  • Biton V. Pharmacokinetics, toxicology and safety of lamotrigine in epilepsy. Expert Opin Drug Metab Toxicol. 2006;2:1009–1018.
  • Kwan P, Sills GJ, Brodie MJ. The mechanisms of action of commonly used antiepileptic drugs. Pharmacol Ther. 2001;90:21–34.
  • George S, Wood AJ, Braithwaite RA. Routine therapeutic monitoring of lamotrigine in epileptic patients using a simple and rapid high performance liquid chromatographic technique. Ann Clin Biochem. 1995;32:584–588.
  • Rambeck B, Wolf P. Lamotrigine clinical pharmacokinetics. Clin Pharmacokinet. 1993;25:433–443.
  • Kilpatrick ES, Forrest G, Brodie MJ. Concentration–effect and concentration–toxicity relations with lamotrigine: a prospective study. Epilepsia. 1996;37:534–538.
  • Hirsch LJ, Weintraub D, Du Y, et al. Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy [Research Support, Non-U.S. Gov’t Review]. Neurology. 2004;63:1022–1026.
  • Yatham LN, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord. 2013;15:1–44.
  • Walpoth-Niederwanger M, Kemmler G, Grunze H, et al. Treatment patterns in inpatients with bipolar disorder at a psychiatric university hospital over a 9-year period: focus on mood stabilizers. Int Clin Psychopharmacol. 2012;27:256–266.
  • Jensen TS. Anticonvulsants in neuropathic pain: rationale and clinical evidence. Eur J Pain. 2002;6:61–68.
  • Backonja M. Neuromodulating drugs for the symptomatic treatment of neuropathic pain. Curr Pain Headache Rep. 2004;8:212–216.
  • Jackson JL, Cogbill E, Santana-Davila R, et al. A comparative effectiveness meta-analysis of drugs for the prophylaxis of migraine headache. PLoS One. 2015;10:e0130733.
  • Johannessen Landmark C, Larsson PG, Rytter E, et al. Antiepileptic drugs in epilepsy and other disorders-a population-based study of prescriptions. Epilepsy Res. 2009;87:31–39.
  • Lofton AL, Klein-Schwartz W. Evaluation of lamotrigine toxicity reported to poison centers. Ann Pharmacother. 2004;38:1811–1815.
  • Moore PW, Donovan JW, Burkhart KK, et al. A case series of patients with lamotrigine toxicity at one center from 2003 to 2012. Clin Toxicol. 2013;51:545–549.
  • Abesamis MG, Pizon A, Walsh S, et al. Accidental lamotrigine overdose in a 20-month old [Conference Abstract]. Clin Toxicol. 2010;48:653.
  • Bouchard N, Halcomb SE, Hoffman RS, et al. Lamotrigine and citalopram overdose: Unmasking a Brugada ECG pattern [Meeting Abstract]. Clin Toxicol. 2006;44:656–656.
  • Chiew AL, Cush K, Chan BSH. Prolonged delirium and abnormal movements in paediatric lamotrigine ingestion [Conference Abstract]. Clin Toxicol. 2013;51:319.
  • Dlugopolski PR, Katz KD, Krenzelok EP. Prolonged CNS toxicity in a child with lamotrigine poisoning [Meeting Abstract]. Clin Toxicol. 2007;45:615–616.
  • Eleftheriou G, Butera R, Faraoni L, et al. Ischemic colitis following duloxetine and lamotrigine poisoning: Is there a relationship? [Conference Abstract]. Clin Toxicol. 2010;48:282.
  • Eleftheriou G, Butera R, Zavaritt A, et al. Dystonic effects and false increase in lactate levels after lamotrigine poisoning [Conference Abstract]. Clin Toxicol. 2009;47:457–458.
  • Harchelroad F, Lang D, Valeriano J. Lamotrigine overdose [Meeting]. Vet Hum Toxicol. 1994;36:372.
  • Hernandez SH, Habib S, Howland MA, et al. Severe prolonged encephalopathy from an intentional lamotrigine overdose with significantly elevated and prolonged serum concentrations [Conference Abstract]. Clin Toxicol. 2010;48:645.
  • Jobst BC, Williamson PD. Status epilepticus as a result of acute lamotrigine intoxication [Meeting Abstract]. Epilepsia. 2005;46:279–279.
  • Lapoint J, Sullivan R, Rey L, et al. Massive, unintentional pediatric lamotrigine overdose resulting in seizures [Conference Abstract]. Clin Toxicol. 2010;48:607.
  • Miller MA, Levsky ME. Choreiform dyskinesia following isolated lamotrigine overdose [Case Reports Letter]. J Child Neurol. 2008;23:243.
  • Williams SR, Watkins B. Lamotrigine poisoning with severe neurotoxicity and cardiac dysrhythmias, treated with hemodialysis [Meeting Abstract]. Clin Toxicol. 2011;49:618–618.
  • Cheema N, Leikin JB. Delayed seizure due to venlafaxine ER and lamotrigine overdose [Conference Abstract]. Clin Toxicol. 2014;52:812–813.
  • Trella J, Lombardo M, Boroughf W, et al. Lamotrigine causes false positive field test for methylenedioxypyrovalerone [Abstract]. Clin Toxicol. 2016;54:659–881.
  • Bartecka-Mino K, Schiel H, Arif T. Lamotrigine enquiries to the Austrian Poisons Information Centre: a retrospective 14-year study [Conference Abstract]. Clin Toxicol. 2017;55:423.
  • Kristen Gruenthera TP, Joseph Y, Anthony P. Lamotrigine toxidrome of rapidly alternating somnolence and agitated delirium [Conference Abstract]. Clin Toxicol. 2016;54:730.
  • Vukovic-Ercegovic G, Perkovic-Vukcevic N, Potrebic O, et al. Acute lamotrigine overdoses treated at the Department of Emergency and Clinical Toxicology during a 3-year period clinical overview [Conference Abstract]. Clin Toxicol. 2017;55:421.
  • Algahtani HA, Aldarmahi AA, Al-Rabia MW, et al. Generalized myoclonus and spasticity induced by lamotrigine toxicity: a case report and literature review. Clin Neuropharmacol. 2014;37:52–54.
  • Braga AJ, Chidley K. Self-poisoning with lamotrigine and pregabalin [Case Reports]. Anaesthesia. 2007;62:524–527.
  • Briassoulis G, Kalabalikis P, Tamiolaki M, et al. Lamotrigine childhood overdose [Case Reports]. Pediatr Neurol. 1998;19:239–242.
  • Buckley NA, Whyte IM, Dawson AH. Self-poisoning with lamotrigine [Case Reports Letter]. Lancet. 1993;342:1552–1553.
  • Castanares-Zapatero D, Wittebole X, Huberlant V, et al. Lipid emulsion as rescue therapy in lamotrigine overdose [Case Reports]. J Emerg Med. 2012;42:48–51.
  • Chavez P, Casso Dominguez A, Herzog E. Evolving electrocardiographic changes in lamotrigine overdose: a case report and literature review. Cardiovasc Toxicol. 2015;15:394–398.
  • Dagtekin O, Marcus H, Muller C, et al. Lipid therapy for serotonin syndrome after intoxication with venlafaxine, lamotrigine and diazepam [Case Reports]. Minerva Anestesiol. 2011;77:93–95.
  • Dinnerstein E, Jobst BC, Williamson PD. Lamotrigine intoxication provoking status epilepticus in an adult with localization-related epilepsy [Case Reports]. Arch Neurol. 2007;64:1344–1346.
  • French LK, McKeown NJ, Hendrickson RG. Complete heart block and death following lamotrigine overdose [Case Reports]. Clin Toxicol. 2011;49:330–333.
  • Herold TJ. Lamotrigine as a possible cause of QRS prolongation in a patient with known seizure disorder [Case Reports]. CJEM. 2006;8:361–364.
  • Kornhall D, Nielsen EW. Failure of ketamine anesthesia in a patient with lamotrigine overdose. Case Rep Crit Care. 2014;2014:916360.
  • Kotwal A, Cutrona SL. Serotonin syndrome in the setting of lamotrigine, aripiprazole, and cocaine use. Case Rep Med. 2015;2015:769531.
  • Lu J, Xiong C, Wang X, et al. Successful treatment of severe lamotrigine and clonazepam poisoning by blood purification [Case Reports Letter]. Blood Purif. 2012;34:18.
  • Nogar JN, Minns AB, Savaser DJ, et al. Severe sodium channel blockade and cardiovascular collapse due to a massive lamotrigine overdose [Case Reports Research Support, U.S. Govt, Non-P.H.S.]. Clin Toxicol. 2011;49:854–857.
  • O'Donnell J, Bateman DN. Lamotrigine overdose in an adult [Case Reports]. J Toxicol Clin Toxicol. 2000;38:659–660.
  • Reimers A, Reinholt G. Acute lamotrigine overdose in an adolescent [Case Reports]. Ther Drug Monit. 2007;29:669–670.
  • Sbei M, Campellone JV. Stupor from lamotrigine toxicity [Case Reports]. Epilepsia. 2001;42:1082–1083.
  • Schwartz MD, Geller RJ. Seizures and altered mental status after lamotrigine overdose [Case Reports]. Ther Drug Monit. 2007;29:843–844.
  • Sethi NK, Douyon P, Kaunzner U, et al. Delayed status epilepticus due to bupropion and lamotrigine overdose. East J Med. 2013;18:142–144.
  • Sirianni AJ, Osterhoudt KC, Calello DP, et al. Use of lipid emulsion in the resuscitation of a patient with prolonged cardiovascular collapse after overdose of bupropion and lamotrigine(done) [Case Reports]. Ann Emerg Med. 2008;51:412–415, 415.e1.
  • Thundiyil JG, Anderson IB, Stewart PJ, et al. Lamotrigine-induced seizures in a child: case report and literature review [Case Reports]. Clin Toxicol. 2007;45:169–172.
  • Venkatraman N, O'Neil D, Hall AP. Life-threatening overdose with lamotrigine, citalopram, and chlorpheniramine(2X) [Case Reports]. J Postgrad Med. 2008;54:316–317.
  • Waring WS. Lamotrigine overdose associated with generalised seizures. BMJ Case Rep. 2009. DOI:10.1136/bcr.07.2008.0489
  • Weiss B, Rothmann C, Weber M, et al. Lamotrigine (Lamictal) acute poisoning: clinical and toxicokinetics correlation. [French] Intoxication aigue par lamotrigine (Lamictal): correlation toxicocinetique et clinique. Jeur. 2002;15:208–210.
  • Willis T, Roper H, Rabb L. Lamotrigine poisoning presenting as seizures: a case of deliberate poisoning [Case Reports]. Child Abuse Negl. 2007;31:85–88.
  • Zidd AG, Hack JB. Pediatric ingestion of lamotrigine(2X) [Case Reports]. Pediatr Neurol. 2004;31:71–72.
  • Grosso S, Ferranti S, Gaggiano C, et al. Massive lamotrigine poisoning. A case report [Case Reports]. Brain Dev. 2017;39:349–351.
  • Hajiali F, Nassiri-Asl M. Report of severe menorrhagia following the maximum amount of lamotrigine overdose. Iran J Pharm Res. 2015;14:1289–1293.
  • Deslandes G, Bouquie R, Lorber J, et al. Status epilepticus following self-poisoning of lacosamide and lamotrigine: a case report with follow-up of drug serum concentrations. Toxicologie Analytique Et Clinique. 2015;27:88–90.
  • Veerapandiyan A, Gallentine WB, Winchester SA, et al. Oculogyric crises secondary to lamotrigine overdosage. Epilepsia. 2011;52:e4–e6.
  • Sander JW, Trevisol-Bittencourt PC, Hart YM, et al. The efficacy and long-term tolerability of lamotrigine in the treatment of severe epilepsy. Epilepsy Res. 1990;7:226–229.
  • Battino D, Croci D, Granata T, et al. Lamotrigine plasma concentrations in children and adults: influence of age and associated therapy. Ther Drug Monit. 1997;19:620–627.
  • Bartoli A, Guerrini R, Belmonte A, et al. The influence of dosage, age, and comedication on steady state plasma lamotrigine concentrations in epileptic children: a prospective study with preliminary assessment of correlations with clinical response [Article]. Ther Drug Monit. 1997;19:252–260.
  • Sorri A, Keranen T, Moilanen E, et al. The effect of oral activated charcoal on the absorption and elimination of lamotrigine. Epilepsia. 1998;39:53.
  • Keranen T, Sorri A, Moilanen E, et al. Effects of charcoal on the absorption and elimination of the antiepileptic drugs lamotrigine and oxcarbazepine [Randomized Controlled Trial Research Support, Non-U.S. Arzneimittelforschung. 2010;60:421–426.
  • De Lera Ruiz M, Kraus RL. Voltage-gated sodium channels: structure, function, pharmacology, and clinical indications. J Med Chem. 2015;58:7093–7118.
  • Chen HY, Albertson TE, Olson KR. Treatment of drug-induced seizures. Br J Clin Pharmacol. 2016;81:412–419.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.